NYSE$YCBD
cbdMD Inc · Q3 2024 earnings
Q3 2024 earnings · · Investor relations
Briefing
YCBD Q3 2024 — $5.2M revenue, 3.00 EPS
These forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results. cbdMD Inc reported Q3 2024 results. Diluted EPS came in at $3.00. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Revenue: $5.2M.
- Diluted EPS: $3.00.
- Operating income: $382K.
- Gross profit: $3.4M.
Headline financials
Revenue & EPS history
cbdMD · Revenue · Quarterly
$5.17M
Revenue by segment
cbdMD · $3.8M total across 1 segment · Q2 2026
- E-commerce sales$3.8M—100.0%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2024
-0.5%
Avg return
Earnings day
-3.1%
Avg return
5 days after
-10.8%
Avg return
30 days after
42%
15 / 36 earnings
Positive
+70.1%
Q2 2020
Best reaction
-22.4%
Q4 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2025 | +0.0% | +5.3% | -38.9% | |
| Q3 2025 | -11.1% | -22.4% | -20.0% | |
| Q2 2026 | -4.0% | -8.2% | -13.2% | |
| Q2 2025 | -4.0% | -8.2% | -13.2% | |
| Q1 2025 | -15.1% | -24.6% | -52.6% | |
| Q4 2024 | -15.7% | -22.1% | +14.4% | |
| Q3 2024 | +3.7% | +2.1% | +7.6% | |
| Q2 2024 | +0.0% | +1.0% | -8.6% | |
| Q1 2024 | -12.3% | -5.5% | -0.7% | |
| Q4 2023 | +7.9% | +6.4% | +17.7% | |
| Q3 2023 | +0.7% | -5.6% | -9.8% | |
| Q2 2023 | -6.9% | -6.0% | -21.6% | |
| Q1 2023 | -5.8% | +1.8% | -28.1% | |
| Q4 2022 | -22.4% | -29.9% | -8.6% | |
| Q3 2022 | -5.9% | -11.6% | -48.4% | |
| Q2 2022 | +8.4% | +28.6% | -31.7% | |
| Q1 2022 | -19.5% | -16.3% | -14.0% | |
| Q4 2021 | +3.5% | +0.9% | -7.1% | |
| Q3 2021 | -5.0% | -7.8% | +3.7% | |
| Q2 2021 | -21.8% | -17.4% | -0.3% | |
| Q1 2021 | +15.2% | -9.2% | -19.4% | |
| Q4 2020 | +15.1% | +6.5% | +6.5% | |
| Q3 2020 | +8.1% | +10.2% | -27.6% | |
| Q2 2020 | +70.1% | +71.1% | +54.6% | |
| Q1 2020 | +2.6% | +0.0% | -40.9% | |
| Q4 2019 | -0.7% | -1.4% | -59.7% | |
| Q3 2019 | -9.4% | -11.6% | -11.4% | |
| Q2 2019 | -3.1% | +0.6% | -2.0% | |
| Q1 2019 | +1.8% | +6.5% | -9.7% | |
| Q4 2018 | -12.4% | -21.1% | +7.2% | |
| Q3 2017 | +14.4% | +1.4% | +13.0% | |
| Q3 2018 | +14.4% | +1.4% | +13.0% | |
| Q2 2017 | -1.2% | -10.2% | -22.3% | |
| Q2 2018 | -1.2% | -10.2% | -22.3% | |
| Q1 2018 | -7.7% | -10.1% | -14.3% | |
| Q4 2017 | +2.9% | +5.3% | +18.6% | |
| Q1 2017 | — | — | — | |
| Q4 2016 | — | — | — | |
| Q3 2016 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro